EVANSMED Stock Overview
Evans Medical Plc manufactures, markets, and distributes health products.
Evans Medical Plc Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||₦0.50|
|52 Week High||₦0|
|52 Week Low||₦0|
|1 Month Change||0%|
|3 Month Change||0%|
|1 Year Change||0%|
|3 Year Change||0%|
|5 Year Change||0%|
|Change since IPO||-51.11%|
Recent News & Updates
|EVANSMED||NG Pharmaceuticals||NG Market|
Return vs Industry: EVANSMED underperformed the NG Pharmaceuticals industry which returned 15.3% over the past year.
Return vs Market: EVANSMED exceeded the NG Market which returned -2.4% over the past year.
|EVANSMED Average Weekly Movement||0%|
|Pharmaceuticals Industry Average Movement||4.2%|
|Market Average Movement||5.4%|
|10% most volatile stocks in NG Market||7.1%|
|10% least volatile stocks in NG Market||2.8%|
Stable Share Price: EVANSMED is less volatile than 75% of NG stocks over the past 3 months, typically moving +/- 0% a week.
Volatility Over Time: EVANSMED's weekly volatility (0%) has been stable over the past year.
About the Company
Evans Medical Plc manufactures, markets, and distributes health products. The company operates in the Over the Counter and Prescriptive segments. Its products include anti-malarials, ant-infectives, anti-asthamatics, anti-histaminics, analgesics, anti-ulcerants, anti-hypertensives, anti-diabetics, cold and cough preparations, erectile dysfunctions, energy supplements, herbal products, haematinics blood forming preparations, prostagladins, vitamins and minerals, topical preparations, and pharyngeals.
Evans Medical Plc Fundamentals Summary
|EVANSMED fundamental statistics|
Is EVANSMED overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|EVANSMED income statement (TTM)|
|Cost of Revenue||₦1.96b|
Last Reported Earnings
Dec 31, 2014
Next Earnings Date
|Earnings per share (EPS)||0|
|Net Profit Margin||0.00%|
How did EVANSMED perform over the long term?See historical performance and comparison